Patent Application
20150196674
1. Field of the Invention
To provide effective, broad spectrum UV-C or alternative controlled ionizing radiation source clinical surface disinfection, high intensity light emitting diodes (LEDs) of incrementally differing wavelengths are sequentially embedded in densely packed reflective nacels (geometrically shaped cups or depressions) forming the surface of a rotating spherical or hemispherical structure. The combination of emitter component location and activation with the rotational and reciprocal elevation functions of such structures produces complete and continuous environmental overlapping energy scattering. Ultraviolet C light (UV-C or UVC) is an ISO Standard for short wave UV light in the 280-100 nm range with energy per photon in the 4.43-12.4 eV range. Alternate ionizing radiation sources include controlled x-ray and gamma emissions.
2. Description of the Related Art
The present invention relates in general to Hospital Acquired Infections (HAI) and the no-touch disinfection of high-touch clinical environment surfaces, which when used in combination with conventional chemical cleaning techniques have been shown effective in increasing patient safety. Commonly used no-touch methods most often in use include the use of hydrogen peroxide vapor or UV-C ultraviolet light irradiation which forms the basis for this invention.
While gaining awareness in the healthcare environment, present UV-C emission devices suffer the inherent problems of: (a) Fundamental design limitations resulting in difficult aiming of the device energy field with respect to critical high-touch patient surfaces which can end up being shadowed in blind spot locations, greatly compromising effective disinfection. Attempts to rectify this problem with reflective room coatings or frequent system repositioning during use are costly and/or disruptive; (b) limited UV-C spectrum emission through the use of mercury discharge or xenon emitters thereby compromising effective disinfection of the wide assortment of prospective HAI pathogens (including MRSA, C. difficile, Acinetobacter, A. baumanni, Vancomycin resistant enterobacter VRE, etc.). While many current UV-C systems exhibit a limited wavelength spectrum of around 253 nm, optimal UV-C disinfection effectiveness occurs through broad as possible use of a 200-280 nm emission spectrum; (c) present systems are heavy, bulky semi-transportable devices presenting significant operator problems in transportation, set-up and operation. They may also lack on-board power and adequate, automated security of operation. They are also relatively costly, thereby limiting their use.
The present invention relates in general to Hospital Acquired Infections (HAI) and the no-touch disinfection of high-touch clinical environment surfaces, which when used in combination with conventional chemical cleaning techniques have been shown effective in increasing patient safety. Commonly used no-touch methods most often in use include the use of hydrogen peroxide vapor or UV-C ultraviolet light irradiation which forms the basis for this invention.
While gaining awareness in the healthcare environment, present UV-C emission devices suffer the inherent problems of: (a) Fundamental design limitations resulting in difficult aiming of the device energy field with respect to critical high-touch patient surfaces which can end up being shadowed in blind spot locations, greatly compromising effective disinfection. Attempts to rectify this problem with reflective room coatings or frequent system repositioning during use are costly and/or disruptive; (b) limited UV-C spectrum emission through the use of mercury discharge or xenon emitters thereby compromising effective disinfection of the wide assortment of prospective HAI pathogens (including MRSA, C. difficile, Acinetobacter, A. baumanni, Vancomycin resistant enterobacter VRE, etc.). While many current UV-C systems exhibit a limited wavelength spectrum of around 253 nm, optimal UV-C disinfection effectiveness occurs through broad as possible use of a 200-280 nm emission spectrum; (c) present systems are heavy, bulky semi-transportable devices presenting significant operator problems in transportation, set-up and operation. They may also lack on-board power and adequate, automated security of operation. They are also relatively costly, thereby limiting their use.
According to the present invention, the device consists of high intensity UV-C light emitting diodes (LEDs) or alternative UV-C emission components of incrementally differing wavelengths which, in association with white light LEDs, are sequentially embedded in densely packed reflective nacels which form the surface of a rotatable spherical or hemispherical structure. Each group of a central nacel and its immediate surrounding partners (a group of 6 in the case of hexagonal nacels) forms a pod, emitting a broad spectrum UV-C energy output. By incrementally re-sequencing each UV-C LED emitter in adjacent pods while rotating and strobing the entire spherical or hemispherical support structure, extreme broad spectrum UV-C energy is evenly diffused over the treatment area. This energy diffusion is further enhanced through continuous reciprocal raising and lowering of the rotating spherical and hemispherical UV-C emitter head structure of the free-standing, mobile embodiment and ceiling or wall mount embodiment of the device during use.
The invention also shows the incorporation of white light LEDs within each reflective nacel, providing the system operator with the initial ability to correctly aim/position the UV-C emitter head relative to treatment surfaces prior to UV-C energy activation.
The invention also shows incorporation of automatic UV-C dosage completion monitoring of treated surfaces, results of which are wirelessly communicated within the system enabling auto-shutdown at service completion.
The invention also shows multi directional, embedded external motion detection sensing providing automatic system shutdown during use should inadvertent human presence be detected in the treatment area.
The invention also shows operator controls to incorporate effective system activation security through the use of microchip embedded operator card readers and associated passcode input keypads.
The invention also shows that each system control unit is individually digitally encoded to its specific system unit (when not hard wired) thereby preventing system cross-talk.
The invention also shows that UV-C energy system activation is time delayed (30 seconds, for example) following operator switch-on, enabling operator departure from the treatment area.
The invention also shows each system to have a prominent emergency switch-off control.
The invention also shows that in the embodiment with a permanent ceiling or wall mounted hemispherical system UV-C emitter, the operator control unit communicates wirelessly with such a unit and displays internal battery condition, if so powered.
The invention also shows that the free-standing mobile embodiment of the device incorporates rechargeable battery power supplies in addition to being AC line powered as desired.
Vertical enclosure tower (3) is, in turn, supported by, and attached to unit base structure (5), which permits device mobility through casters (6). Base structure (5) also contains internal rechargeable battery/AC line driven system power supplies.
Operator mobility control of the described embodiment is provided through handle (7) which also provides enclosure for system control panel (8).
Activation of the described embodiment allows opening of enclosure doors (4) and structure (1) to rise vertically on structure (2) from structure (3). The rise level of structure (2) is determined by the operator to allow optimal height of structure (1) relative to treatment surfaces in its environment. This is accomplished through use of white light system aiming emitters (16) contained in the emitting structure (1).
When optimal system emitter structure (1) aiming is completed and automatic UV-C dosage sensors (13) strategically deployed and activated, the system UV-C start-up is completed, resulting in a (30 second, for example) activation time delay, permitting operator departure from the treatment area. Continuous rotation of UV-C emitting structure (1) begins in conjunction with operator determined steady state or multi-second strobed high intensity overlapping UV-C energy diffusion into the treatment area, enhanced by operator selected reciprocal vertical action of support tube (2).
At automatic or operator pre-selected UV-C dosage sensors (13) cycle completion, or by operator manual control, system shut-down is effected and UV-C emitter structure (1) retracts into protective tower (3). This would also happen automatically should motion detectors (9) determine inadvertent human presence during system activation.
Functionality of the permanent ceiling or wall mount hemispherical UV-C emission embodiment of the device is fundamentally similar with the exclusion of system aiming (completed at installation).
The present invention is therefore directed to:
(A) A spherical, hemispherical, or other geometric shape high energy UV-C emitter head device.
(B) The emitter head device surface consists of densely packed reflective nacels of hexagonal or other geometric cross section.
(C) Each reflective nacel incorporates a high energy UV-C light emitting diode (LED), or other equivalent UV-C energy emitter component.
(D) Each reflective nacel also incorporates a white (or other visible) light LED for emitter head aiming.
(E) Activation power of the high energy UV-C emitter component may be of a steady state nature or strobed multiple times per second.
(F) Each reflective nacel and its immediately surrounding reflective nacels form a pod. Incremental sequencing of differing wavelength high energy UV-C emitter components within a pod produces broad spectrum UV-C energy output from each pod.
(G) Incremental re-sequencing of the pods further enhances the overall diffusion of the broad spectrum high energy UV-C emission from the emitter head assembly.
(H) Rotation of the emitter head assembly further enhances the overall diffusion of the broad spectrum high energy UV-C emission and allows broad treatment area with even UV-C coverage.
(I) Reciprocal vertical motion of the UV-C emitter head assembly in both embodiments of the device further enhances even treatment area coverage by the high energy UV-C emission.
(J) Automatic UV-C dosage sensors monitor effective UV-C irradiation of treatment surfaces during device activation and communicate this data wirelessly to the device for system shut-down once UV-C irradiation is complete.
(K) Multiple system activation and usage security controls are incorporated into the device consisting of (but not limited to):
(L) System power supplies may be of a rechargeable/battery type or AC line power.
(M) Embodiments of the device may be configured as a free-standing mobile systems or treatment area specific permanent mount systems for ceiling or wall attachment.
This application claims the benefit under Title 35 United States Code §119(e) of U.S. Provisional Patent Application Ser. No. 61/915,450 filed Dec. 12, 2013, the full disclosure of which is incorporated herein by reference.
| Number | Date | Country | |
|---|---|---|---|
| 61915450 | Dec 2013 | US |
